Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia

Radiation Protection Dosimetry

Volumn 132, Issue 2, 2008, Pages 130-133

  Schrappe, Martin ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK ASSESSMENT; RISK FACTORS;

EID: 58549116356     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncn289     Document Type: Article

References (23)

1. Arico, M., Valsecchi, M. G., Camitta, B., Schrappe, M., Chessells, J. and Baruchel, A. et al. Outcome of treatment in children with Philadelphia chromosome - positive acute lymphoblastic leukemia. N. Eng. J. Med. 342 (14), 998-1006 (2000).
2. Pieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G. and Felice, M. et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): An observational study and a multicentre randomised trial. Lancet 370 (9583), 240-250 (2007).
3. Pui, C. H., Gaynon, P. S., Boyett, J. M., Chessells, J. M., Baruchel, A. and Kamps, W. et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359(9321), 1909-1915 (2002).
4. Nachman, J. B., Heerema, N. A., Sather, H., Camitta, B., Forestier, E. and Harrison, C. J. et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 110 (4), 1112-1115 (2007).
5. Janka-Schaub, G. E., Stührk, H., Kortüm, B., Graubner, U., Haas, R. J. and Göbel, U. et al. Bone marrow blast count at day 28 as the single most important prognostic factor in childhood acute lymphoblastic leukemia. Haematol. Blood Transfus. 34, 233-237 (1992).
6. Silverman, L. B., Gelber, R. D., Young, M. L., Dalton, V. K., Barr, R. D. and Sallan, S. E. Induction failure in acute lymphoblastic leukemia of childhood. Cancer 85 (6), 1395-1404 (1999).
7. Reiter, A., Schrappe, M., Ludwig, W. D., Hiddemann, W., Sauter, S. and Henze, G. et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84(9), 3122-3133 (1994).
8. Gaynon, P. S., Desai, A. A., Bostrom, B. C., Hutchinson, R. J., Lange, B. J. and Nachman, J. B. et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review. Cancer 80, 1717-1726 (1997).
9. Kager, L., Lion, T., Attarbaschi, A., Koenig, M., Strehl, S. and Haas, O. A. et al. Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children. Haematologica 92 (11), 1561-1564 (2007).
10. Gajjar, A., Harrison, P. L., Sandlund, J. T., Rivera, G. K., Ribeiro, R. C. and Rubnitz, J. E. et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood 96(10), 3381-3384 (2001).
11. Burger, B., Zimmermann, M., Mann, G., Kuhl, J., Loning, L. and Riehm, H. et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture. J. Clin. Oncol. 21, 184-188 (2003).
12. Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W. and Gaynon, P. et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J. Clin. Oncol. 14, 18-24 (1996).
13. Schrappe, M., Reiter, A., Ludwig, W.-D., Harbott, J., Zimmermann, M. and Hiddemann, W. et al. Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: Results of trial ALL-BFM 90. Blood 95(11), 3310-3322 (2000).
14. Schrauder, A., Reiter, A., Gadner, H., Niethammer, D., Klingebiel, T. and Kremens, B. et al. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95. J. Clin. Oncol. 24(36), 5742-5749 (2006).
15. Balduzzi, A., Valsecchi, M. G., Uderzo, C., De Lorenzo, P., Klingebiel, T. and Peters, C. et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study. Lancet 366 (9486), 635-642 (2005).
16. Cario, G., Izraeli, S., Teichert, A., Rhein, P., Skokowa, J. and Moricke, A. et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J. Clin. Oncol. 25(30), 4813-4820 (2007).
17. Conter, V., Valsecchi, M. G., Silvestri, D., Campbell, M., Dibar, E. and Magyarosy, E. et al. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: A multicentre randomised trial. Lancet 369(9556), 123-131 (2007).
18. van Dongen, J. J. M., Seriu, T., Panzer-Grumayer, E. R., Biondi, A., Pongers-Willemse, M. J. and Corral, L. et al. Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: A prospective study of the International BFM Study Group. Lancet 352 1731-1738 (1998).
19. Willemse, M. J., Seriu, T., Hettinger, K., d'Aniello, E., Hop, W. C. and Panzer-Grumayer, E. R. et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 99(12), 4386-4393 (2002).
20. van der Velden, V. H., Panzer-Grumayer, E. R., Cazzaniga, G., Flohr, T., Sutton, R. and Schrauder, A. et al. Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting. Leukemia 21(4), 706-713 (2007).
21. Szczepanski, T., Orfao, A., van der Velden, V. H., San Miguel, J. F. and van Dongen, J. J. Minimal residual disease in leukaemia patients. Lancet Oncol. 2(7), 409-417 (2001).
22. Cario, G., Stanulla, M., Fine, B. M., Teuffel, O., Neuhoff, N. V. and Schrauder, A. et al. Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia Blood 105(2), 821-826 (2005).
23. Stanulla, M., Schaeffeler, E., Flohr, T., Cario, G., Schrauder, A. and Zimmermann, M. et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 293(12), 1485-1489 (2005).